RISDIPLAM Intermediates CAS No 1825352-86-0 Pharmaceutical Intermediates
overview
2,8-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-B]pyridazine is a special compound that has attracted attention from the pharmaceutical industry due to its unique structural properties and potential therapeutic applications. The compound has a complex imidazo-pyridazine structure and a dioxaborolan moiety, which enhances its reactivity and biological activity.
Therefore, 2,8-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-B]pyridazine has been increasingly explored for its role in drug development, especially in the synthesis of novel therapeutic agents for various diseases.
Physical and chemical properties
- Solubility: Soluble in organic solvents such as DMSO and methanol, with limited solubility in water, facilitating its use in various formulations.
- Stability: The compound exhibits good stability under the recommended storage conditions, stored in a cool and dry place away from direct sunlight, with a shelf life of up to two years.
These properties make 2,8-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-B]pyridazine an ideal candidate for further research and development in the pharmaceutical field.
1. Targeted Therapeutic Potential: The unique structure of this compound can interact with specific biological pathways, making it a promising candidate for the development of new therapies.
2. High Efficiency: Preliminary studies have shown that the compound may exhibit significant efficacy in preclinical models, particularly in oncology and infectious diseases, paving the way for future clinical applications.
3. Custom Synthesis Capabilities: Our facility has the capability to provide custom synthesis services, which can be modified to meet specific customer requirements and improve production efficiency.
4. Quality Assurance: We adhere to strict quality control measures to ensure our products meet or exceed industry standards for purity and potency.
5. Comprehensive Support: Our company provides extensive support to researchers and pharmaceutical companies, including detailed product information and application guidance.
2,8-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-B]pyridazine is primarily used in drug development in the pharmaceutical industry. Its unique molecular structure and potential therapeutic applications make it a valuable asset in the search for new treatments for complex diseases.
Researchers are particularly interested in its role in targeting specific pathways in cancer and infectious diseases, which are in urgent need of innovative solutions.
In conclusion, 2,8-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-B]pyridine is a high-quality compound with important applications in the pharmaceutical industry. Its favorable physical and chemical properties, coupled with our commitment to quality and customer satisfaction, make us an ideal partner for your chemical supply needs.
As a factory integrating production and trading, we ensure that this compound is produced according to the highest standards, providing researchers and pharmaceutical developers with a reliable and effective choice.
Contact us today to learn more about how we can support your pharmaceutical projects with quality products.specific pathways in cancer and neurological diseases, areas where innovative solutions are urgently needed.